Bronchiolitis remains the leading cause of hospital admission in infancy and of paediatric intensive care unit use.1 Management of bronchiolitis has been largely limited to supportive care, reflecting ...
A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for ...
Scientists have developed a new lung surfactant that is produced synthetically rather than relying on the use of animal tissues. With further development, the formulation could provide a cheaper and ...
In a recent study posted to the bioRxiv* preprint server, researchers discuss the role of a surfactant-mediated inflammatory response employed by human lungs against the severe acute respiratory ...
Computerised chest radiograph analysis revealed that the surfactant treatment led to better aeration in the right lung than in the left lung among infants born extremely preterm with respiratory ...
Scientists have developed a new lung surfactant that is produced synthetically rather than relying on the use of animal tissues. With further development, the formulation could provide a cheaper and ...
Lysine shows promise in acute lung injury by restoring lung repair mechanisms and improving survival. Learn more about this ...
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced a manuscript titled, ...
Savara Inc. (the "Company") (Nasdaq: SVRA), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results